Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12065421 Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Patent 12065421 was granted and assigned to Promega on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Promega

Current Assignee

Promega

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120654210

Patent Inventor Names

Christopher Todd Eggers0

Mary Hall0

Joel R. Walker0

Horacio Lazaro0

Date of Patent

August 20, 2024

Patent Application Number

178416130

Date Filed

June 15, 2022

Patent Citations

‌

US Patent 9797889 Activation of bioluminescence by structural complementation

‌

US Patent 8557970 Synthetic

‌

US Patent 8669103 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use

‌

US Patent 9797890 Activation of bioluminescence by structural complementation

Patent Primary Examiner

CPC Code

...

Patent abstract

Compounds that may selectively inhibit

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12065421 Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API